Medtronic broadens its diabetes device portfolio with MiniMed Go Smart MDI system launch across Europe The integrated ...
On the heels of its debut as a public company, Medtronic’s former diabetes division MiniMed has claimed a European approval to connect its mainstay insulin pump with an exclusive continuous glucose ...
MDT launches MiniMed Go Smart MDI with the Simplera sensor in Europe, advancing connected insulin care as the Diabetes unit's IPO plans progress.
Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the commercial launch in Europe of the MiniMed Go™ Smart MDI system with the Simplera™ sensor. The system, which is the ...
Insulin therapy is central to type 1 diabetes and many cases of type 2. It lowers glucose effectively, yet it also introduces predictable risks. Understanding side effects helps patients plan […] ...
The Global Diabetes Devices Market is projected to expand at a compound annual growth rate (CAGR) of approximately 6% by 2026 ...
Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!
Medtronic (NYSE:MDT) has launched its MiniMed Go Smart MDI system with the Simplera sensor in Europe. The system connects the InPen smart insulin pen and a continuous glucose sensor into a single ...
ILLEGAL fake weight loss jabs are now being sold in pubs and fish and chip shops, a concerning report has revealed. The ...
A Wigan man found dead at home had previously threatened to end his life by taking an overdose of medication, an inquest heard.
One of the more frequent questions I get asked is, “Hey Doc, I’ve got this medicine that’s a few months past its expiration; is it still safe to use? Will ...
The Print on MSN
As semaglutide goes off patent, weight-loss gold rush begins. Pharma bets big, court case lingers
Several leading Indian drugmakers have already secured regulatory approval or recommendations to produce and market generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results